Also, because it has been reported that the Srebf2 pathway and the resulting cholesterol flux contribute to the generation of LXR agonists required for the transcriptional activity of SREBP1c (Rong et al, 2017), differences in diet may create differences between human NASH and mouse models. Here, SREBF2 is linked to metabolic dysfunction-associated steatohepatitis.